We are live on
!
Find out more
SC
Salzman & Co Portfolio holdings
AUM
$29.7M
1-Year Est. Return
12.12%
This Fund
S&P 500
This Quarter
Est. Return
-12.37%
1 Year Est. Return
-12.12%
3 Year Est. Return
-15.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$62.8M
AUM Growth
–
Cap. Flow
+$65.3M
Cap. Flow
% of AUM
104.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$28.8M |
| 2 |
Edwards Lifesciences
EW
|
+$23.2M |
| 3 |
Cencora
COR
|
+$13.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.81% |
| 2 | Technology | 43.19% |
Similar funds
BIM
QCMA
GP
AIM
MF
SCM
OI
CC
Salzman & Co's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Salzman & Co, which disclosed 3 positions worth $62.8M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Cognizant: 866,292 shares worth $27.1M.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, followed by Technology.
- Salzman & Co's largest Q2 2013 buy was Cognizant: 866,292 shares worth $27.1M.
- Salzman & Co's ten largest holdings make up 100% of its $62.8M portfolio in Q2 2013.
- Salzman & Co disclosed 3 positions in Q2 2013, its first 13F filing on record.
Based on Salzman & Co's 13F filing for Q2 2013, filed 13 Aug 2013.